IFNA1 and systemic lupus erythematosus: Systemic lupus erythematosus (SLE) is a chronic multisystem autoimmune disease characterized by the production of autoantibodies and overactivation of the type I interferon (IFN) pathway, with alternating exacerbations and remissions (1).